Best Genomics Companies in Finland
The 32 best Genomics companies in Finland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Blueprint Genetics.
- Genomics Market Size to Reach US$ 72.13 Billion by 2030
- Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 202
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Finland
| # | Company | Last round | Disclosed funding | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aavagen Developer of gene tests designed to benefit horse training and breeding | — | — | Unfunded | — | Maria Jensen Co-Founder & CEO | — | 2 patents Predictive genomics for racehorse performance assessment | — |
| 2 | Abacus Diagnostica DNA-based POC diagnostic instruments and assays. | — | — | Funding Raised | 12 | — | — | 42 patents Patents concentrated in chemistry & materials | — |
| 3 | BasePlayer Provider of bioinformatics tool for sequence analysis | — | — | Unfunded | — | Riku Katainen Founder | — | — | — |
| 4 | Biomedicum Genomics Provider of genomic services to life science research purpose | — | — | Unfunded | — | Outi Monni Co-Founder | — | — | — |
| 5 | BN Products and Services Products and Services for Genomics, Proteomics, Drug Discovery, Clinical Chemistry and Cell Biology | — | — | Deadpooled | — | Stuart Webb Co-Founder | — | 98 patents Fire suppression systems and electrical distribution hardware, including protective casings | — |
| 6 | CM Technologies Developer of cell imaging products. The company's product Cell-IQ enables real-time monitoring of… | — | — | Acquired | 50 | — | — | — | — |
| 7 | Finnzymes Manufacturer of scientific instruments for molecular biology analysis designed to improve the performance of… | — | — | Acquired | 90 | — | — | 49 patents Patents concentrated in chemistry & materials | — |
| 8 | GeneAccount Provider of pharmacogenetic test for personalized medicines | — | — | Unfunded | — | Klaus Elenius Co-Founder | — | — | — |
Top 12 Genomics companies in Finland
#1
Public · Kaarina, Southwest Finland · founded 2008 · 28 employees$3.5Mraised▾
MetGen develops and produces genetically modified eco-friendly enzymes that break down lignin. MetGen’s enzymes are industrial, highly-active, natural catalysts that accelerate chemical reactions. The company claims the use of MetGen enzyme leads to energy saving during the pulping process in paper manufacturing, reduced costs and improved yield in production of bioethanol from cellulosic waste and purification of water from phenolic compounds and lignin.
- Jan 2024Grant (prize money)$680.7K
- May 2021Grant (prize money)$711.6K
- Feb 2019Grant (prize money)—
- Jan 2019Series A$571K
#2
Seed · Helsinki, Uusimaa · founded 2022$1.1Mraised▾
Cloud based platform for real time genomic pathogen surveillance and epidemiology. It enables users to track outbreaks, build responses, and prevent infections using genomic data. The platform integrates genomic data into real time surveillance with a privacy focused approach.
- Jun 2023Seed$1.1M
#3
Public · Helsinki, Uusimaa · founded 2013 · 64 employees$23Mraised▾
Provider of a metabolomic technology platform for blood analysis and research. The company has proprietary mass-scale blood analysis technology the company has developed disease detection tests. The platform utilizes NMR spectroscopy to directly measure 220 metabolites in the blood sample to look for signatures indicative of diseases such as diabetes and cardiovascular disease. The company's platform can also be used for biomarker discovery to develop new tests.
- Jan 2021Grant (prize money)$308.4K
- Dec 2019Seed—
- Jan 2019Conventional Debt$22.7M
#4
Acquired · Espoo, Uusimaa · founded 2012 · 143 employees$26.2Mraised▾
Provider of genetic diagnostics and clinical interpretation for hereditary diseases. The company offers comprehensive clinical-grade NGS with gapless sequencing and medical statements. Its technologies include OS-Seq, a targeted sequencing technology. The company claims to cover more than 2,000 genes with its NGS platform. It also provides targeted NGS panels and Del/Dup analysis, medical Exome, whole Exome, and CNV analysis. It can be used in the diagnostic of diseases like cardiovascular, dermatological, ENT, endocrine, gastric, hematological, hereditary cancer, immunology, metabolic, renal, neural, ophthalmic, and respiratory diseases.
- Jul 2017Series B$16M
- Aug 2014Series A$3.9M
- Series B$6.3M
#5
Seed · Espoo, Uusimaa · founded 2010 · 20 employees$391Kraised▾
Euformatics offers bioinformatics tools to interpret next-gen sequencing data. The company has two products omnomicsQ and omnomicsNGS. omnomicsQ is a software that enables quality control of sequencing data, in compliance with EuroGentest and CAP guidelines. omnomicsNGS is a software platform for pateint NGS data that provides all relevant genomic and mutation information for clinicians and molecular genetics laboratories to aid diagnosis. Both products have a cloud-based and a standalone version.
- Jul 2022Grant (prize money)$365.7K
- Jan 2019Grant (prize money)$834.9K
- Sep 2016Seed$391K
#6
Funding Raised · Kuopio, North Savo · founded 1990 · 201 employees$2.5Mraised▾
FinVector, (originally founded as Ark Therapeutics by Professor Seppo Ylä-Herttuala in the mid-90s) is engaged in the research and development of viral-based gene therapy products. The company has over 20 years of experience in virus development and manufacturing. The company has experience in HEK293, HEK293T, A549, and other cell lines. The company has capabilities to work with a broad range of viral vectors, mainly Adenoviruses (recombinant, oncolytic), Adeno Associated Virus (AAV) and Lentivirus and can develop and manufacture them using either serum-free suspension bioreactor approaches or controlled and disposable fixed bed bioreactor processes. The company's scalable serum-free suspension culture-based manufacturing process platform for adenoviruses (ATOSUS) has been used for clinical supply. The company's services include process development and scale-up, cGMP manufacturing, aseptic filling, stability studies, cell banking and viral seed stocks, assay development and regulatory support. Their GMP facility is approved by EU regulators.
- Jan 2019Grant (prize money)$1.8M
- Jan 2017Grant (prize money)$649.4K
#7
Deadpooled · Helsinki, Uusimaa · founded 2007$4.2Mraised▾
Plex Press is a spin-off from Finnish technology research center. It has developed a gene expression analysis platform called TRAC technology, originally developed for gene expression analysis in bioprocess applications. The company claims to have engaged in more than 50 projects using this TRAC technology in the field of Pharma and research.
- Apr 2012Seed$1.4M
- May 2009Seed$2.8M
#8
Acquired · Helsinki, Uusimaa · founded 2007$4.2Mraised▾
High throughput gene expression analysis
#9
Deadpooled · Tampere, Pirkanmaa · founded 1995 · 11 employees$1Mraised▾
FIT Biotech is engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU) technology. GTU technology is used in DNA vaccines and gene therapy (antibody-based cancer treatment and autoimmune diseases). Using its technology, the company is using immunotherapy for HIV; therapeutic vaccines for tuberculosis, human papillomavirus (HPV) and ebola. The HIV immunotherapy is currently in Phase IIa trials, while the others are in preclinical stages.
- Jan 2016Grant (prize money)$1M
#10
Seed · Helsinki, Uusimaa · founded 2009 · 12 employees$1Mraised▾
MediSapiens is a bioinformatics company, based in Helsinki, Finland and Cambridge, Massachusetts, with a background in pharmaceutical research and translational genomics. The company provides pharmaceutical and biomedical research organizations with tools that help them design more effective personalized drugs against life-threatening diseases. MediSapiens creates powerful and intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data. The company's goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation.
- Jun 2010Seed$1M
#11
Funding Raised · Tampere, Pirkanmaa · founded 2011$319.4Kraised▾
Genevia Technologies provides full-service bioinformatics support for research and industries. The company provides complete omics analyses for biopharma companies, research institutions, and diagnostics companies. In addition, it also provides analysis software for automating pipeline analyses and workflows.
- May 2019Grant (prize money)—
- Mar 2019Grant (prize money)$319.4K
#12
Series B · Turku, Varsinais-suomi · founded 2015 · 14 employees—raised▾
Provider of next-generation diagnostic solutions. The company uses Geno1 technology to provide NGS-based solutions. The company provides diagnostics and risk monitoring tests in the following category Color (for the risk of developing ovarian and breast cancer), Guardant 360 ( liquid biopsy test ), Biocept (Liquid biopsy-based on CTC + ctDNA sequencing), and NIPT (non-invasive prenatal testing for trisomy).
- Sep 2023Series B—
- Dec 2019Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Finland
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 276 Finland-affiliated papers.
- University of Helsinki77
- Institute for Molecular Medicine Finland31
- University of Turku29
- Helsinki University Hospital26
- Tampere University22
- Genome1→14
- Drug1→6
- Annotation1→4
- Transcriptome1→4
- Gene1→8
- Microbiome5
- Gene4
- Computational biology3
- Gut microbiome3
- Gut flora3
Where bioinformatics is researched across Finland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.